These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34309458)

  • 41. Overexpression of FADD enhances 5-fluorouracil-induced apoptosis in colorectal adenocarcinoma cells.
    Yin A; Jiang Y; Zhang X; Luo H
    Med Oncol; 2010 Jun; 27(2):397-405. PubMed ID: 19415536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis.
    Chong D; Ma L; Liu F; Zhang Z; Zhao S; Huo Q; Zhang P; Zheng H; Liu H
    Anticancer Drugs; 2017 Sep; 28(8):831-840. PubMed ID: 28816773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer.
    Lin PM; Lee HM; Huang CI; Tai TS; Chen JH; Chen CI; Su YC
    Anticancer Res; 2020 Nov; 40(11):6265-6271. PubMed ID: 33109564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
    Li XL; Wang CZ; Mehendale SR; Sun S; Wang Q; Yuan CS
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1097-104. PubMed ID: 19277659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
    Yang C; Pan Y; Deng SP
    BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
    Wang Y; Liu X; Liu J; Zhang T
    Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination of p53 codon 72 polymorphism and inactive p53 mutation predicts chemosensitivity to 5-fluorouracil in colorectal cancer.
    Tominaga T; Iwahashi M; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Higashiguchi T; Oku Y; Nasu T; Yamaue H
    Int J Cancer; 2010 Apr; 126(7):1691-701. PubMed ID: 19810096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.
    Wang W; Guo W; Li L; Fu Z; Liu W; Gao J; Shu Y; Xu Q; Sun Y; Gu Y
    Biochem Pharmacol; 2016 Dec; 121():8-17. PubMed ID: 27693317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients.
    Backus HH; Dukers DF; van Groeningen CJ; Vos W; Bloemena E; Wouters D; van Riel JM; Smid K; Giaccone G; Pinedo HM; Peters GJ
    Ann Oncol; 2001 Feb; 12(2):209-16. PubMed ID: 11300326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer.
    Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW
    Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Luteolin induces mitochondria-dependent apoptosis in human lung adenocarcinoma cell.
    Chen Q; Liu S; Chen J; Zhang Q; Lin S; Chen Z; Jiang J
    Nat Prod Commun; 2012 Jan; 7(1):29-32. PubMed ID: 22428236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells.
    Xavier CP; Lima CF; Preto A; Seruca R; Fernandes-Ferreira M; Pereira-Wilson C
    Cancer Lett; 2009 Aug; 281(2):162-70. PubMed ID: 19344998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Yun S; Han YS; Lee JH; Kim S; Lee SH
    Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Thymidine phosphorylase expressed in monocyte-macrophages enhanced anticancer effect of 5'-deoxy-5-fluorouridine on colorectal carcinoma cells].
    Zhang JM; Liu MJ; Mizoi T; Shiiba K; Sasak I; Matsuno S
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):718-24. PubMed ID: 15200906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
    Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
    Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase of Bax/ Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line.
    Chang J; Hsu Y; Kuo P; Kuo Y; Chiang L; Lin C
    Life Sci; 2005 Mar; 76(16):1883-93. PubMed ID: 15698865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic Effect of Forbesione From Garcinia hanburyi in Combination with 5-Fluorouracil on Cholangiocarcinoma.
    Boueroy P; Hahnvajanawong C; Boonmars T; Saensa-ard S; Wattanawongdon W; Kongsanthia C; Salao K; Wongwajana S; Anantachoke N; Reutrakul V
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3343-3351. PubMed ID: 29286229
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer.
    Khan N; Jajeh F; Eberhardt EL; Miller DD; Albrecht DM; Van Doorn R; Hruby MD; Maresh ME; Clipson L; Mukhtar H; Halberg RB
    Int J Cancer; 2019 Dec; 145(11):3022-3032. PubMed ID: 31018249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.